Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ila14
    Junior Member
    • Jan 2014
    • 3

    #1

    RNA-Seq for transposon insertion analysis

    Hello all,
    I am a new student to bioinformatics and CLC genomics so would be grateful for any help given as I'm feeling slightly lost.

    I have been given illumina data (fastq files) consisting of the genome sequences to a bacterial genome, initially to perform single- end RNA-Seq analysis and differential expression analysis.
    My main focus is to find: The number of mutants.
    The number of transposon insertions in total.
    The number of transposon insertions per gene.

    I have three conditions: Starting, first output and second output i.e. 3 groups.
    I have replicate sequencing data for the first output and second output data however I only have one set of data for the starting.

    Using CLC genomics, I have been able to trim my sequences, map them to an annotated genome and perform RNA-Seq analysis.
    (An example to aid simplicity of my explanation. My experiment contains 1 starting library, 3 first output replicates and 3 second output replicates).
    To start my comparison, I did a box plot of the three groups. This revealed that the individual samples all have a similar distributions, especially with respect to their own group although, the locations of the distributions differed. Because of this, I normalized my samples by quantile normalization which indeed made the samples comparable exemplified by a box plot showing each sample as having an equal distribution. Was this the right thing to do? Should I have chosen a different normalization method?

    Next, I performed a statistical test on the proportions of the two groups using the starting library as the reference. I performed an unpaired Baggerley test of the three groups and chose the RPKM as the expression value to be used in the test.
    (see manual here http://www.clcsupport.com/clcgenomic...oportions.html )

    Now what I am unsure of the following things:
    What is the easiest way to identify insertions into the genome through the data without individually checking the read mapped onto each gene?
    What is the correct way to normalize my data?
    Statistically what is the best test to use?
    What values are most important for my test?
    Should I use the fold-change, total gene reads or unique gene reads instead of the RPKM for the expression value to be used in the test?

    Thanks in advance

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Yesterday, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 02:55 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...